Rebecca B Perkins1, Mengyun Lin2, Rebecca A Silliman3, Jack A Clark4, Amresh Hanchate5. 1. Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts. Electronic address: rebeccabperkins@gmail.com. 2. Department of Medicine, Division of General Internal Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts. 3. Department of Medicine, Division of Geriatrics, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts. 4. Boston University School of Public Health, Edith Nourse Rogers Veterans Hospital, Boston, Massachusetts. 5. Veterans Affairs Boston Healthcare System, Boston University School of Medicine, Boston, Massachusetts.
Abstract
BACKGROUND: Human papilloma virus (HPV) vaccination rates in the United States remain low, compared with other recommended adolescent vaccines. We compared factors associated with intention to receive and receipt of HPV and meningococcal vaccines and completion of the HPV vaccine series among U.S. adolescent girls. METHODS: Secondary analysis of data from the National Immunization Survey-Teen for 2008 through 2012 was performed. Multivariable logistic modeling was used to determine factors associated with intent to receive and receipt of HPV and meningococcal vaccination, completion of the HPV vaccine series among girls who started the series, and receipt of HPV vaccination among girls who received meningococcal vaccination. FINDINGS: Provider recommendation increased the odds of receipt and intention to receive both HPV and meningococcal vaccines. Provider recommendation was also associated with a three-fold increase in HPV vaccination among girls who received meningococcal vaccination (p<.001), indicating a relationship between provider recommendation and missed vaccine opportunities. However, White girls were 10% more likely to report provider recommendation than Black or Hispanic girls (p<.01), yet did not have higher vaccination rates, implying a role for parental refusal. No factors predicted consistently the completion of the HPV vaccine series among those who started. CONCLUSION: Improving provider recommendation for co-administration of HPV and meningococcal vaccines would reduce missed opportunities for initiating the HPV vaccine series. However, different interventions may be necessary to improve series completion.
BACKGROUND:Human papilloma virus (HPV) vaccination rates in the United States remain low, compared with other recommended adolescent vaccines. We compared factors associated with intention to receive and receipt of HPV and meningococcal vaccines and completion of the HPV vaccine series among U.S. adolescent girls. METHODS: Secondary analysis of data from the National Immunization Survey-Teen for 2008 through 2012 was performed. Multivariable logistic modeling was used to determine factors associated with intent to receive and receipt of HPV and meningococcal vaccination, completion of the HPV vaccine series among girls who started the series, and receipt of HPV vaccination among girls who received meningococcal vaccination. FINDINGS: Provider recommendation increased the odds of receipt and intention to receive both HPV and meningococcal vaccines. Provider recommendation was also associated with a three-fold increase in HPV vaccination among girls who received meningococcal vaccination (p<.001), indicating a relationship between provider recommendation and missed vaccine opportunities. However, White girls were 10% more likely to report provider recommendation than Black or Hispanic girls (p<.01), yet did not have higher vaccination rates, implying a role for parental refusal. No factors predicted consistently the completion of the HPV vaccine series among those who started. CONCLUSION: Improving provider recommendation for co-administration of HPV and meningococcal vaccines would reduce missed opportunities for initiating the HPV vaccine series. However, different interventions may be necessary to improve series completion.
Authors: Lila J Finney Rutten; Jennifer L St Sauver; Timothy J Beebe; Patrick M Wilson; Debra J Jacobson; Chun Fan; Carmen Radecki Breitkopf; Susan T Vadaparampil; Kathy L MacLaughlin; Robert M Jacobson Journal: Vaccine Date: 2017-09-27 Impact factor: 3.641
Authors: Jessica L Krok-Schoen; Brittany M Bernardo; Rory C Weier; Juan Peng; Mira L Katz; Paul L Reiter; Morgan S Richardson; Michael L Pennell; Cathy M Tatum; Electra D Paskett Journal: J Rural Health Date: 2017-11-14 Impact factor: 4.333
Authors: Richard K Zimmerman; Jonathan M Raviotta; Mary Patricia Nowalk; Krissy K Moehling; Evelyn Cohen Reis; Sharon G Humiston; Chyongchiou Jeng Lin Journal: Vaccine Date: 2017-09-22 Impact factor: 3.641
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641
Authors: Terresa J Eun; Amresh Hanchate; Anny T Fenton; Jack A Clark; Marisa N Aurora; Mari-Lynn Drainoni; Rebecca B Perkins Journal: Hum Vaccin Immunother Date: 2019-04-16 Impact factor: 3.452
Authors: Teri L Malo; Karla N Ali; Steven K Sutton; Rebecca B Perkins; Anna R Giuliano; Susan T Vadaparampil Journal: Hum Vaccin Immunother Date: 2016-02-02 Impact factor: 3.452